TY - JOUR T1 - The characteristics of oxygen concentration and the role of correction factor in real-time GI Breath Test JF - medRxiv DO - 10.1101/2020.10.22.20213876 SP - 2020.10.22.20213876 AU - Siu Man Lee AU - Imogen HE Falconer AU - Trudi Madden AU - Peter O Laidler Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/23/2020.10.22.20213876.abstract N2 - A high quality end-expiratory breath sample is required for a reliable GI breath test result. Oxygen (O2) concentration in the breath sample can be used as a quality marker. This study investigated the characteristics of oxygen concentration in breath sample and the issues with using a correction factor in real-time breath test. The results indicated 95.4% of 564 patients were able to achieve an O2 concentration below 14% in their end-expiratory breath. A further 293 samples were studied and revealed that the distribution of O2 concentration was between 16.5% and 9.5%. Applying a correction factor to predict the end-expiratory H2 and CH4 values led to an average error of −36.4% and −12.8% respectively. The correction factor algorithm based on limiting O2 at 14% would have resulted in false negative result for 50% of the positive cases. This study has also indicated the continuous O2 measurement is essential to ensure breath sample quality by preventing secondary breathing during real-time breath collection.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe clinical data is publicly available.Funding StatementThe authors received no external funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data used in this study is openly available to the public, under the Freedom of Information Act 2000 in the United Kingdom.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study is openly available to the public, under the Freedom of Information Act 2000 in the United Kingdom. The source data can be accessed via the web page of the Royal United Hospitals Bath NHS Foundation Trust. The specific address is provided in the section: Data Availability Links. https://www.ruh.nhs.uk/MPB/documents/Service_data_2020b.pdf ER -